Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |